Actavis is one of the world's leading companies specializing in the development, manufacture and sale of generic pharmaceuticals. Actavis has operations in more than 40 countries, with 11,000 employees.

In 2007, Actavis expects sales to reach EUR1.6bn, with approximately one-third of these sales coming from the United States, the Company's single largest market. In Europe in 2006, the Company filed 669 MAs and had over 370 new product and market launches. In 2007, Actavis had over 500 product and market launches.